Your browser doesn't support javascript.
loading
A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia.
Cheung, Matthew C; Mittmann, Nicole; Owen, Carolyn; Abdel-Samad, Nizar; Fraser, Graeme A M; Lam, Selay; Crump, Michael; Sperlich, Catherine; van der Jagt, Richard; Prica, Anca; Couban, Stephen; Woyach, Jennifer A; Ruppert, Amy S; Booth, Allison M; Mandrekar, Sumithra J; McDonald, Gail; Shepherd, Lois E; Yen, Hope; Chen, Bingshu E; Hay, Annette E.
Afiliação
  • Cheung MC; Division of Hematology, Department of Medicine, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada; Canadian Cancer Trials Group, Queens University, Kingston, Canada. Electronic address: matthew.cheung@sunnybrook.ca.
  • Mittmann N; Canadian Cancer Trials Group, Queens University, Kingston, Canada; Department of Pharmacology and Toxicology and Institute for Health Policy Management and Evaluation, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
  • Owen C; Foothills Medical Centre and Tom Baker Cancer Centre, Calgary, Canada.
  • Abdel-Samad N; Division of Hematology, The Moncton Hospital, Moncton, Canada.
  • Fraser GAM; Department of Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, Canada.
  • Lam S; Victoria Hospital, Western University, London, Canada.
  • Crump M; Canadian Cancer Trials Group, Queens University, Kingston, Canada; Division of Hematology, Department of Medicine, Princess Margaret Hospital and University of Toronto, Toronto, Canada.
  • Sperlich C; Centre integre de Santé et de Services Sociaux de la Montérégie-Centre, Greenfield Park, Canada.
  • van der Jagt R; Hematology, Ottawa Hospital, University of Ottawa, Ottawa, Canada.
  • Prica A; Canadian Cancer Trials Group, Queens University, Kingston, Canada; Division of Hematology, Department of Medicine, Princess Margaret Hospital and University of Toronto, Toronto, Canada.
  • Couban S; Canadian Cancer Trials Group, Queens University, Kingston, Canada; Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, Canada.
  • Woyach JA; Division of Hematology, The Ohio State University, Columbus, OH.
  • Ruppert AS; Division of Hematology, The Ohio State University, Columbus, OH; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN.
  • Booth AM; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN; Department of Quantitative Health Sciences, and Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN.
  • Mandrekar SJ; Department of Quantitative Health Sciences, and Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN.
  • McDonald G; Canadian Cancer Trials Group, Queens University, Kingston, Canada.
  • Shepherd LE; Department of Pharmacology and Toxicology and Institute for Health Policy Management and Evaluation, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
  • Yen H; Canadian Cancer Trials Group, Queens University, Kingston, Canada.
  • Chen BE; Canadian Cancer Trials Group, Queens University, Kingston, Canada.
  • Hay AE; Canadian Cancer Trials Group, Queens University, Kingston, Canada; Department of Medicine, Queen's University, Kingston, Ontario, Canada.
Clin Lymphoma Myeloma Leuk ; 21(11): 766-774, 2021 11.
Article em En | MEDLINE | ID: mdl-34334330
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperidinas / Adenina / Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Cloridrato de Bendamustina / Rituximab Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperidinas / Adenina / Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Cloridrato de Bendamustina / Rituximab Idioma: En Ano de publicação: 2021 Tipo de documento: Article